Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fermented lactoferrin is possible infant formula ingredient, Agennix tells LSRO.

This article was originally published in The Tan Sheet

Executive Summary

AGENNIX FERMENTED LACTOFERRIN POSSIBLE INFANT FORMULA INGREDIENT, President and CEO Denis Headon, PhD, suggested at an open meeting on micronutrient requirements for preterm infant formulas. The meeting, sponsored by the Federation of American Societies for Experimental Biology Life Sciences Research Office, was held in Bethesda, Md. March 27. LSRO has been commissioned by FDA to conduct a review of current infant formula standards and nutritional requirements of both term and preterm infants, and compile the information and its recommendations in two reports ("The Tan Sheet" Nov. 18, 1996, p. 6). LSRO expects to complete the report on preterm infant formulas in the fall.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088262

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel